Literature DB >> 18984970

The relationship between the extracellular matrix and the angiogenesis and metastasis of laryngeal carcinoma.

Zhao Han1, Guo-Jing Lin, Fang-Lu Chi, Shu-Yi Wang, Jian-Min Huang, Hong-Jian Liu, Lu-Rong Zhang.   

Abstract

AIMS: We studied the relationships between the growth, metastasis and angiogenesis of laryngeal carcinoma and extracellular matrix protein-1 (ECM1) and hyaluronan (HA).
METHODS: Thirty-three cases of benign and malignant laryngeal tumors were included. Using immunohistochemical staining, we examined the expression of ECM1 and HA in tumors and metastatic lymph nodes and correlated it with counts of microvessel density.
RESULTS: The expression of ECM1 (p = 0.004) and HA (p = 0.036) was significantly different between benign and malignant tumors. The expression of ECM1 was strongly associated with microvessel density (Spearman's rho = 0.513, p = 0.017), with the strongest expression present within caner nests. With respect to HA, expression was significantly associated with more advanced clinical TNM stage (Spearman's rho = 0.521, p = 0.015). The link was stronger in cases where metastasis or recurrence occurred than in those without complication (p = 0.014). No significant relationship was found between ECM1 and HA expression among malignant samples (Spearman's rho = 0.383, p = 0.087).
CONCLUSIONS: ECM1 has a high association with the growth, metastasis and angiogenesis of laryngeal carcinoma. An increased level of HA expression was related to the process of laryngeal carcinogenesis. Specifically, carcinoma cells with high levels of HA secretion had a higher potential for metastasis. No significant relative expression of ECM1 and HA was found. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18984970     DOI: 10.1159/000163030

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  6 in total

1.  Extracellular matrix protein 1, a novel prognostic factor, is associated with metastatic potential of hepatocellular carcinoma.

Authors:  Hao Chen; Wei-Dong Jia; Jian-Sheng Li; Wei Wang; Ge-Liang Xu; Jin-Liang Ma; Wei-Hua Ren; Yong-Sheng Ge; Ji-Hai Yu; Wen-Bin Liu; Chuan-Hai Zhang; Yong-Cang Wang
Journal:  Med Oncol       Date:  2010-12-03       Impact factor: 3.064

2.  Extracellular matrix 1 (ECM1) regulates the actin cytoskeletal architecture of aggressive breast cancer cells in part via S100A4 and Rho-family GTPases.

Authors:  P Gómez-Contreras; J M Ramiro-Díaz; A Sierra; C Stipp; F E Domann; R J Weigel; G Lal
Journal:  Clin Exp Metastasis       Date:  2016-10-21       Impact factor: 5.150

3.  Correlation of ECM1 expression level with the pathogenesis and metastasis of laryngeal carcinoma.

Authors:  Meizhen Gu; Jian Guan; Limin Zhao; Kun Ni; Xiaoyan Li; Zhao Han
Journal:  Int J Clin Exp Pathol       Date:  2013-05-15

Review 4.  Tumor angiogenesis and lymphangiogenesis: tumor/endothelial crosstalk and cellular/microenvironmental signaling mechanisms.

Authors:  Fausto Gueths Gomes; Fernanda Nedel; Alessandro Menna Alves; Jacques Eduardo Nör; Sandra Beatriz Chaves Tarquinio
Journal:  Life Sci       Date:  2012-11-21       Impact factor: 5.037

5.  Novel Function of Extracellular Matrix Protein 1 in Suppressing Th17 Cell Development in Experimental Autoimmune Encephalomyelitis.

Authors:  Pan Su; Sheng Chen; Yu Han Zheng; Hai Yan Zhou; Cheng Hua Yan; Fang Yu; Ya Guang Zhang; Lan He; Yuan Zhang; Yanming Wang; Lei Wu; Xiaoai Wu; Bingke Yu; Li Yan Ma; Zhiru Yang; Jianhua Wang; Guixian Zhao; Jinfang Zhu; Zhi-Ying Wu; Bing Sun
Journal:  J Immunol       Date:  2016-06-17       Impact factor: 5.422

Review 6.  Collection on reports of molecules linked to epithelial-mesenchymal transition in the process of treating metastasizing cancer: a narrative review.

Authors:  Yiyi Cai; Boyuan Wang; Bingying Li; Xintong Huang; Haoyue Guo; Yu Liu; Bin Chen; Sha Zhao; Shengyu Wu; Wei Li; Lei Wang; Keyi Jia; Hao Wang; Peixin Chen; Minlin Jiang; Xuzhen Tang; Hui Qi; Chunlei Dai; Junyan Ye; Yayi He
Journal:  Ann Transl Med       Date:  2021-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.